Kingsley Napley advises Harwell Campus on development, lease arrangement, and construction for Moderna
Moderna, a biotechnology business developing mRNA treatments and vaccines, chose Harwell for its Moderna Innovation and Technology Centre (MITC).
The MITC expansion will include a research, development, and manufacturing facility that will offer cutting-edge mRNA vaccines for a variety of respiratory disorders to the UK public, pending regulatory approval. Â A Northumberland-built modular clinical biomarker laboratory will be put at the MITC.
![Pasted image 0](https://lawfirmrankingsreport.com/wp-content/uploads/pasted-image-0-173.png)
Peter Metcalfe, Partner
The Kingsley Napley team was led by Partner Peter Metcalfe and Associate Cameron Mason (Construction).
Peter said:Â “We are delighted to support our long standing client, Harwell Campus, on this ground breaking development and all of the associated construction work streams. Â We wish Harwell Campus and their contractor, Glencar Construction, the best of luck during the construction phase.”
![Pasted image 0](https://lawfirmrankingsreport.com/wp-content/uploads/pasted-image-0-179.png)
Cameron Mason, Associate
For detailed information, as well as the picture copyright, please see the law firm’s original article here: Kingsley Napley advises Harwell Campus on development, agreement for lease and construction for Moderna.